AFC-HD AMS Life Science Reports Large

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on January 16, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

AFC-HD AMS Life Science Reports Large Exercise of Sixth Tranche Warrant

Source disclosure: January 16, 2026 AFC-HD AMS Life Science Co., Ltd. [2927.T] TOKYO, Jan 16 (Pulse News Wire) – Afc-hd AMS Life Science CO.,LTD. (2927.T) reported the large-scale exercise of its sixth tranche warrant during the period from January 5 to January 16, 2026. The warrants, issued to EVO Fund on July 31, 2025, saw the delivery of 55,000 shares on January 16, bringing the total exercised warrants to 950 out of a total issuance of 1,400 warrants. As of January 16, there rem